Advancements in APOE and dementia research: Highlights from the 2023 AAIC Advancements: APOE conference
Courtney M. Kloske(Alzheimer's Association), Ryan A. Tuckey(Frederick National Laboratory for Cancer Research), Julia TCW(Allen Institute for Brain Science), Simin Mahinrad(Alzheimer's Association), Kapil V. Ramachandran(Columbia University Irving Medical Center), Justin J. Miller(Washington University in St. Louis), Elizabeth Blue(University of Washington), Celeste M. Karch(Washington University in St. Louis), Costantino Iadecola(Weill Cornell Medicine), Francesca Garretti(Icahn School of Medicine at Mount Sinai), Andrea Soranno(Washington University in St. Louis), Paige E. Lawler(Washington University in St. Louis), Lance A. Johnson(Oregon Health & Science University), Yadong Huang(Gladstone Institutes), Edoardo Marcora(Icahn School of Medicine at Mount Sinai), Aiko Robert(Cognitive Research (United States)), María C. Carrillo(Alzheimer's Association), Gregory R. Bowman(Washington University in St. Louis), Francis Shue(Jacksonville College), Marlies Oosthoek(Amsterdam University Medical Centers), Lesley R. Golden(University of Kentucky), Bruce T. Lamb(Cleveland Clinic Lerner College of Medicine), Claire E. Sexton(Alzheimer's Association), Jay W. Heinecke(Washington University in St. Louis), Takahisa Kanekiyo(Jacksonville College), Li‐Huei Tsai(Broad Institute), Albert A. Davis(Hope Center for Neurological Disorders), Claudia Mariño(Massachusetts Eye and Ear Infirmary), Rasha N.M. Saleh(University of East Anglia), Josh M. Morganti(American Physical Therapy Association), Michel Satya Naslavsky(Universidade de São Paulo), David Gate(Northwestern University), Abhirami Ramakrishnan(Northwestern University), Manon Thierry(New York University), Gilbert Di Paolo(Columbia University Irving Medical Center), Ornit Chiba‐Falek(Duke University), Chia‐Chen Liu(Xiamen University), Joachim Herz, Ana‐Caroline Raulin(Jacksonville College), Isabel J. Sible(University of Southern California), Priyanka Narayan(National Institute of Diabetes and Digestive and Kidney Diseases), Michaël E. Belloy(Washington University in St. Louis), Xiaoying Chen(Washington University in St. Louis), Alexandra Litvinchuk(Hope Center for Neurological Disorders), Sascha J. Koppes‐den Hertog(Cognitive Research (United States)), Anastasia Khvorova(University of Massachusetts Chan Medical School), Nilomi Shah(Lexmark (United States)), Michael R. Strickland(Washington University in St. Louis), D. M. Michaelson(Tel Aviv University), Yann Le Guen(Stanford Medicine)
Cited by 30
Related Papers
National Institute on Aging–Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease
|Alzheimer s & Dementia|2012|3.2k
National Institute of Neurological Disorders and Stroke–Canadian Stroke Network Vascular Cognitive Impairment Harmonization Standards
|Stroke|2006|1.7k
Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions.
|Journal of Clinical Investigation|1994|1.3k
APOE4 Causes Widespread Molecular and Cellular Alterations Associated with Alzheimer’s Disease Phenotypes in Human iPSC-Derived Brain Cell Types
|Neuron|2018|1.1k
Inflammation and Stroke: An Overview
|Neurotherapeutics|2016|951